The inhibition or genetic silencing of TRPM2 has been shown to sensitize melanoma cells to oxidative stress and reduce their capacity to withstand cytotoxic insults, thereby enhancing the efficacy of chemotherapeutic agents [60]. This evidence concerns the gene TRPM2 and melanoma.